Nature Reviews Cardiology: Atherosclerosis is a chronic inflammatory disease of the arterial wall with multiple immune mediators implicated in its pathogenesis. Despite the wide range of anti-inflammatory drugs already in use to treat immune disorders, studies to determine whether anti-inflammatory therapies can improve cardiovascular outcomes are necessary before these treatments become a part of cardiovascular prevention. In this Review, Bäck and Hansson describe existing therapies in use for inflammatory diseases and explore the therapeutic potential of targeting immune activation in patients with atherosclerosis. http://bit.ly/1DBaSc2 (£)
Search